Iobenguane
Back to searchMolecule Structure
Scientific Name
Iobenguane
Description of the Drug
Iobenguane is a radiopharmaceutical agent used for the diagnosis of primary and metastatic pheochromocytoma or neuroblastoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06704
http://www.drugbank.ca/drugs/DB06704
Brand Name(s)
Not Available
Company Owner(s)
Ge Healthcare, Pharmalucence Inc, Progenics Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Norepinephrine transporter | SINGLE PROTEIN | SUBSTRATE | CHEMBL222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL140591 | |||
| Human Metabolome Database | HMDB0253507 | |||
| DrugBank | DB06704 | |||
| PubChem: Thomson Pharma | 14750688 | |||
| PubChem | 60860 | |||
| LINCS | LSM-2969 | |||
| Nikkaji | J360.168D | |||
| EPA CompTox Dashboard | DTXSID4048438 | |||
| rxnorm | IOBENGUANE I-131 | 3-IODOBENZYLGUANIDINE | AZEDRA | IOBENGUANE SULFATE I-123 |
| ChEBI | 92769 | |||
| ZINC | ZINC000001538318 |
